News & Press

Massachusetts' new sales & marketing regulations took effect July 1, 2009.

Under the regulations, Pharmaceutical or Medical Device Manufacturing Companies (PMDMCs) must track and report expenditures related to sales & marketing activities.

Today is the deadline for companies who fall under the purview of the statute to:

• Certify compliance with a Code of Conduct
• Submit information requested in Section 970.005 of the regulations (name of compliance officer, investigation policies, etc.)
• Submit an annual fee of $2,000

The Massachusetts Biotechnology Council today announced its collaboration with Indigo Insurance Services, LLC, a wholly-owned subsidiary of Blue Cross Blue Shield of Massachusetts.

Indigo was chosen as a Primary Supplier in the MBC Purchasing Consortium to provide MBC member companies access to ancillary insurance benefits.

The June edition of the MBC News is in the mail. The MBC News is a quarterly publication sent to all member companies and many of Massachusetts' opinion leaders to showcase what is taking place in the biotechnology industry.

Click Full Story below to read the full Q&A with Dr. Windham-Bannister.

Newsletter advertising and sponsorship opportunities are available. Just call 617-674-5100 or email communications@massbio.org.

The Massachusetts Biotechnology Council has begun videotaping its popular Committee Meetings for easy playback.

Can't make it to Cambridge for a meeting? No problem-- simply find the video playback on www.massbio.org.

Watch today's Finance Committee meeting--Biotechnology 2009: The State of the Industry and its Implications -- brought to you by Cubist Pharmaceuticals.

The Massachusetts Biotechnology Council's new Telepresence Center is now open for business for companies seeking to save time and money using videoconferences or webcasts.

The Telepresence Center, which has a 100-person capacity, was recently equipped with state-of-the-art Polycom cameras and microphones to allow companies and organizations to boost productivity and conduct business with global partners-- all from the convenience of an office down the street.

In the Message of Hope radio series, you hear real stories of three Massachusetts researchers and a clinical trials manager who work each day to produce cures for unmet medial needs. These talented individuals come from a cross-section of the Massachusetts Biotechnology Council Membership (MBC): an academic research institution, a small biotechnology company with 15 employees, a medium sized, public biotechnology company pushing for their first product, and a large biopharmaceutical company working on its next promising therapy.